Kaveri Seed Grants 1,42,352 Stock Options Under ESOP Plan 2024
Kaveri Seed Company Limited's Nomination and Remuneration Committee approved the grant of 1,42,352 stock options to employees under the ESOP Plan 2024. The options are exercisable into equity shares at ₹790 per option. Vesting begins after one year, spread over four years.
ESOP grants are a common employee incentive and typically have a limited direct impact on the company's immediate financial performance or stock price, unless the scale is exceptionally large or unusual.
The announcement details a routine ESOP grant to employees, which is a standard corporate practice and does not inherently indicate positive or negative performance. The terms are clearly defined as per the existing plan.
Kaveri Seed Company Limited has announced an outcome from the meeting of its Nomination and Remuneration Committee (NRC). The committee has approved the grant of 1,42,352 stock options to eligible employees under the Kaveri Seed Employee Stock Option Plan 2024.
These options are exercisable into an equivalent number of fully paid-up equity shares of ₹2 each. The shares were acquired by the Kaveri Employees Trust through the secondary market route. The grant is in accordance with the terms of the ESOP Plan 2024, as approved by the company's shareholders.
The exercise price for each option has been determined at ₹790 per option, based on the pricing formula stipulated in the ESOP plan. The vesting schedule indicates that vesting will commence after one year from the grant date, with options vesting over the next four years in the ratio of 20%, 20%, 25%, and 35%. The options can be exercised at any time within a maximum period of four years from the date of vesting, up to March 30, 2030.
This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Regulations), 2015, read with SEBI (Share Based Employee Benefits and Securities Premium) Regulations, 2021.
What to do with a filing like this
Kaveri Seed Company Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kaveri Seed Company Limited. Read the original for the full detail.